NIHO evaluated Epidyolex with clobazam for Dravet and Lennox-Gastaut syndromes from age two. Its assessment considered clinical and economic evidence for a defined medicine and indications.[1]
Listed for context. No score change is recorded for Slovakia here.
References
Checked. The date and the event were compared with a source that was read.